1. GPCR/G Protein Neuronal Signaling
  2. Dopamine Receptor Arrestin
  3. D1/D5 Receptor agonist-1

D1/D5 Receptor agonist-1 是一种具有血脑屏障通透性并且具有口服活性的 D1/D5 受体 (D1/D5 receptor) 激动剂。D1/D5 Receptor agonist-1 在 cAMP 途径和 β-arrestin 募集方面保持显著疗效,其 EC50 值分别为 3.7 nM (D1R cAMP)、91 nM (D1R β-arrestin)、129 nM (D1R 内化),对 D1R 结合亲和力的 Ki 值为 111 nM。D1/D5 Receptor agonist-1 在大鼠中抑制 L-DOPA (HY-N0304) 诱导的运动障碍中的 β-arrestin 信号传导。D1/D5 Receptor agonist-1 可用于帕金森病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

D1/D5 Receptor agonist-1

D1/D5 Receptor agonist-1 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

D1/D5 Receptor agonist-1 is a highly brain-penetrant and orally active D1/D5 receptor agonist. D1/D5 Receptor agonist-1 maintains considerable efficacy in the cAMP pathway and in β-arrestin recruitment, with EC50s of 3.7 nM (D1R cAMP), 91 nM (D1R β-arrestin), 129 nM (D1R internalization) and a Ki of 111 nM (D1R binding affinity). D1/D5 Receptor agonist-1 inhibits β-arrestin signaling in a rat with L-DOPA (HY-N0304) induced dyskinesias. D1/D5 Receptor agonist-1 can be used for the study of Parkinson’s disease[1].

IC50 & Target[1]

D1 Receptor

 

D5 Receptor

 

体外研究
(In Vitro)

D1/D5 Receptor agonist-1 (Compound 24) (10-4-10 μM) 在 cAMP 途径和 β-arrestin 蛋白募集方面保持显著疗效,其 EC50 值分别为 3.7 nM (D1R cAMP)、91 nM (D1R β-arrestin)、129 nM (D1R 内化) ,对 D1R 结合亲和力的 Ki 值为 111 nM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

D1/D5 Receptor agonist-1 (Compound 24) (0.3-3 mg/kg,口服,单次给药) 在 L-DOPA (HY-N0304) 诱导的帕金森病大鼠异动症模型中抑制 β-arrestin 信号传导[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 6-OHDA and L-DOPA (HY-N0304)-induced dyskinesias in adult male SD rats (180 g)[1]
Dosage: 0.3, 1, 3 mg/kg
Administration: p.o. for a single dose
Result: Decreased EEG beta power over a longer time course (up to 4 h).
Showed comparable efficacy to a therapeutic dose of L-DOPA and with significantly fewer concomitant dyskinesias at doses with predicted D1 RO of 30 to 50%.
分子量

368.32

Formula

C18H13FN4O4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
D1/D5 Receptor agonist-1
目录号:
HY-175001
需求量: